Cargando...
Testosterone, HDL and cardiovascular risk in men: the jury is still out
“Even when reductions in HDL-cholesterol are observed as a consequence of androgen therapy, the implications for cardiovascular risk modification remain highly uncertain.”
Guardado en:
| Publicado en: | Clin Lipidol |
|---|---|
| Autores principales: | , |
| Formato: | Artigo |
| Lenguaje: | Inglês |
| Publicado: |
2012
|
| Materias: | |
| Acceso en línea: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4219622/ https://ncbi.nlm.nih.gov/pubmed/25379057 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2217/clp.12.38 |
| Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|